Huang DS - Search Results

1

Prognostic impact of tumor size on isolated hepatocellular carcinoma without vascular invasion may have age variance.

Zhang Y, Zhang JG, Yu W, Liang L, Wu C, Zhang CW, Xie YM, Huang DS, Shi Y. Zhang Y, et al. Among authors: huang ds. Front Surg. 2023 Jan 6;9:988484. doi: 10.3389/fsurg.2022.988484. eCollection 2022. Front Surg. 2023. PMID: 36684156 Free PMC article.

2

MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.

Zhang JG, Shi Y, Hong DF, Song M, Huang D, Wang CY, Zhao G. Zhang JG, et al. Sci Rep. 2015 Jan 28;5:8087. doi: 10.1038/srep08087. Sci Rep. 2015. PMID: 25627001 Free PMC article.

3

FSCN‑1 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition.

Zhang Y, Lu Y, Zhang C, Huang D, Wu W, Zhang Y, Shen J, Cai Y, Chen W, Yao W. Zhang Y, et al. Int J Oncol. 2018 May;52(5):1455-1464. doi: 10.3892/ijo.2018.4327. Epub 2018 Mar 20. Int J Oncol. 2018. PMID: 29568938 Free PMC article.

4

Interaction of long-chain non-coding RNAs and important signaling pathways on human cancers (Review).

Sun W, Shi Y, Wang Z, Zhang J, Cai H, Zhang J, Huang D. Sun W, et al. Int J Oncol. 2018 Dec;53(6):2343-2355. doi: 10.3892/ijo.2018.4575. Epub 2018 Sep 27. Int J Oncol. 2018. PMID: 30272345 Review.

5

Corrigendum: MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.

Zhang JG, Shi Y, Hong DF, Song M, Huang D, Wang CY, Zhao G. Zhang JG, et al. Sci Rep. 2017 Aug 24;7:46886. doi: 10.1038/srep46886. eCollection 2017. Sci Rep. 2017. PMID: 31305788 Free PMC article.

6

The state of minimally invasive pancreaticoduodenectomy in Chinese mainland: A systematic literature review.

Ding J, Zhang C, Huang D, Zhang Y. Ding J, et al. Biosci Trends. 2020 Jan 20;13(6):488-501. doi: 10.5582/bst.2019.01278. Epub 2019 Dec 24. Biosci Trends. 2020. PMID: 31875583 Free article. Review.

7

Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer.

Jiang J, Ye S, Xu Y, Chang L, Hu X, Ru G, Guo Y, Yi X, Yang L, Huang D. Jiang J, et al. Front Oncol. 2020 Jul 30;10:1220. doi: 10.3389/fonc.2020.01220. eCollection 2020. Front Oncol. 2020. PMID: 32850360 Free PMC article.

8

Gallbladder neuroendocrine carcinoma: A single center experience.

Chu H, Zhang C, Shi Y, Wu W, Hu Z, Zhang J, Huang D. Chu H, et al. Medicine (Baltimore). 2020 Sep 4;99(36):e21912. doi: 10.1097/MD.0000000000021912. Medicine (Baltimore). 2020. PMID: 32899024 Free PMC article.

9

Update in clinical management for gallbladder neuroendocrine carcinoma.

Chu H, Shi Y, Liu J, Huang D, Zhang J, Dou C. Chu H, et al. Medicine (Baltimore). 2021 Apr 9;100(14):e25449. doi: 10.1097/MD.0000000000025449. Medicine (Baltimore). 2021. PMID: 33832150 Free PMC article.

10

Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma.

Zeng Z, Lu Q, Liu Y, Zhao J, Zhang Q, Hu L, Shi Z, Tu Y, Xiao Z, Xu Q, Huang D. Zeng Z, et al. Front Oncol. 2021 Jul 7;11:641522. doi: 10.3389/fonc.2021.641522. eCollection 2021. Front Oncol. 2021. PMID: 34307125 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters